iMineIVF
iMineIVF generates an estimated $1–$9/month in revenue from 1–2 downloads/month on the App Store, according to AppCurrents estimates (updated 2026-08-02).
| Est. revenue / month | $1–$9 |
|---|---|
| Est. downloads / month | 1–2 |
| Estimate confidence | medium |
| Pricing | Paid $2.99 |
| Rating | 1.00 ★ (1 ratings) |
| Category | Medical |
| Released | 15.05.2013 |
| App last updated | 04.09.2025 |
| Platform | iOS |
Modeled monthly estimate · rating velocity · medium confidence
About
iMineIVF v.5 patient app now provides fertility clinics a complete suite of functionalities aimed at exchanging live instructions, communications and admission tickets with their patients while in treatment. Navigation includes: - Clinic credentials (Clinic ID + 3-letters identifier) issued at admissions - Published cycle instructions, prescriptions + video tutorials - Health reports + personaliz…
Trends & analysis
Chart rank trend
US · overallWhy it's surfacing
Scout 12Ratings & velocity
★ 0 in windowRating distribution
0% positive · 1 ratingsGeographic reach
best rank · 3 storefrontsRevenue & downloads trend
ARPU $2Update history
1 update tracked- v5.011mo ago
- Updated + enhanced login functionalities - Patient appointments suite - Push notifications for any treatment updates - Revised documents management - Danish language support - Minor bug fixes + optimization
iMineIVF — FAQ
How much money does iMineIVF make?
According to AppCurrents estimates, iMineIVF generates approximately $1–$9 per month (medium confidence), modeled from its the App Store chart performance, rating velocity, and monetization signals.
How many downloads does iMineIVF get?
iMineIVF sees an estimated 1–2 downloads per month on the App Store, per AppCurrents modeling.
Is iMineIVF free?
iMineIVF is a paid app priced at $2.99 on the App Store.
What is iMineIVF's rating?
iMineIVF holds a 1.00-star average from 1 ratings on the App Store.
When was iMineIVF released?
iMineIVF launched on the App Store on 15.05.2013. Its latest version shipped 04.09.2025.
